Yellow Reduced PQQ Crystals via Ascorbic Acid Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for producing reduced pyrroloquinoline quinone (PQQ) crystals face challenges such as toxicity from reducing agents, explosive hydrogen use, high costs, low water solubility, and difficulty in forming light-colored crystals suitable for food and pharmaceutical applications.
Innovation Solution
A method involving the reduction of pyrroloquinoline quinone using ascorbic acid at controlled temperatures and pH, resulting in yellow reduced PQQ crystals with enhanced solubility and stability, and a composition with cyclodextrin for improved dispersibility and solubility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional reducing agents (sodium borohydride, sodium dithionite) are used to reduce oxidized PQQ, then reduced PQQ can be obtained, but toxicity is introduced requiring additional removal steps
Solution Approach 1:
The patent uses ascorbic acid, a safe and inexpensive reducing agent that can be easily removed from the final product, replacing toxic reducing agents like sodium borohydride and sodium dithionite that require complex removal steps. Ascorbic acid's short-lived nature in the reaction allows for simple purification by filtration and washing, eliminating the need for sophisticated toxicity removal facilities.
2Reliability
If hydrogen gas is used as reducing agent with platinum catalyst, then reduced PQQ can be obtained, but explosive hazards require special facilities
Solution Approach 1:
The patent replaces hydrogen gas with ascorbic acid as the reducing agent. Ascorbic acid is a stable, non-explosive solid that can be handled safely without special facilities. The reduction reaction proceeds under mild conditions at room temperature, eliminating the need for expensive hydrogen handling equipment, catalysts, and specialized explosion-proof facilities.
3Reliability
If conventional recrystallization with dimethyl sulfoxide and acetonitrile is used, then reduced PQQ crystals can be obtained, but organic solvent residues remain requiring additional treatment
Solution Approach 1:
The patent changes the crystallization parameters by using water as the solvent instead of organic solvents like dimethyl sulfoxide and acetonitrile. The reduced PQQ is recrystallized from aqueous solution at controlled temperatures (0-25°C), yielding pure yellow crystals free from organic solvent residues. This parameter change eliminates the need for additional solvent removal treatment and allows direct use in food and pharmaceutical applications.
4Quantity of substance
If conventional black reduced PQQ crystals are used, then they can be obtained through simple reduction, but they have low solubility in water and alcohol making them difficult to use in liquid forms
Solution Approach 1:
The patent changes the crystallization parameters including temperature control (0-25°C), pH adjustment (2.0-4.0), and solvent selection (water-based) to produce yellow reduced PQQ crystals with enhanced solubility. These yellow crystals exhibit significantly higher solubility in water (0.04-0.20 mg/mL) and alcohol compared to conventional black crystals, enabling direct use in liquid food and pharmaceutical formulations without requiring aprotic solvents like dimethyl sulfoxide.
5Illumination intensity
If conventional black reduced PQQ crystals are used, then they can be obtained, but their dark color makes them unsuitable for food and cosmetic applications
Solution Approach 1:
The patent changes the crystallization parameters including temperature (0-25°C), pH (2.0-4.0), and oxidation potential control to produce yellow reduced PQQ crystals instead of black crystals. The yellow color results from controlled crystallization conditions that prevent over-oxidation and aggregation. This color improvement makes the product suitable for food, cosmetic, and pharmaceutical applications where appearance is critical.
6Reliability
If column chromatography is used for purification, then reduced PQQ can be obtained, but expensive facilities and large amounts of extraction solution are required
Solution Approach 1:
The patent extracts and purifies reduced PQQ through simple filtration and washing steps instead of using column chromatography. The reduced PQQ crystals are filtered directly from the aqueous reaction mixture and washed with water to remove impurities. This extraction approach eliminates the need for expensive column chromatography facilities and large amounts of organic extraction solvents, significantly reducing production costs while maintaining high purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces yellow reduced PQQ crystals with high solubility and stability, suitable for food and pharmaceutical applications, avoiding the limitations of conventional methods and ensuring safety and cost-effectiveness.
Implementation Method 1
a method involving the reduction of pyrroloquinoline quinone using ascorbic acid
Implementation Method 2
a composition with cyclodextrin for improved dispersibility and solubility
Data Source
AI summary
A yellow reduced pyrroloquinoline quinone crystal having a solubility in water of 0.040 to 0.20 (mg/mL).